369 related articles for article (PubMed ID: 21210358)
1. [Evolution and Diversity of HIV-1].
Metzner KJ
Praxis (Bern 1994); 2011 Jan; 100(1):29-35. PubMed ID: 21210358
[TBL] [Abstract][Full Text] [Related]
2. Intra-host evolution of human immunodeficiency virus type 1 and viral fitness.
Clementi M; Canducci F; Bagnarelli P; Menzo S
New Microbiol; 2004 Apr; 27(2 Suppl 1):41-4. PubMed ID: 15646063
[TBL] [Abstract][Full Text] [Related]
3. The clades of HIV: their origins and clinical significance.
Stebbing J; Moyle G
AIDS Rev; 2003; 5(4):205-13. PubMed ID: 15011999
[TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
6. Genetic Consequences of Antiviral Therapy on HIV-1.
Arenas M
Comput Math Methods Med; 2015; 2015():395826. PubMed ID: 26170895
[TBL] [Abstract][Full Text] [Related]
7. [HIV eradication--facts and fiction].
Jaeger H; Wolf E
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():72-3. PubMed ID: 19024923
[No Abstract] [Full Text] [Related]
8. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
9. The multiple benefits associated with HIV drug-resistance mutation M184V.
Bean P
Am Clin Lab; 2002 Mar; 21(2):16-8. PubMed ID: 11993249
[No Abstract] [Full Text] [Related]
10. [HIV genetic diversity and its consequences].
Roquebert B; Damond F; Brun-Vézinet F; Descamps D
Pathol Biol (Paris); 2009 Mar; 57(2):142-8. PubMed ID: 18511216
[TBL] [Abstract][Full Text] [Related]
11. Diversity, drug resistance, and the epidemic of subtype C HIV-1 in Africa.
Katzenstein D
J Infect Dis; 2006 Sep; 194 Suppl 1():S45-50. PubMed ID: 16921472
[TBL] [Abstract][Full Text] [Related]
12. [Antiretroviral resistance in human immunodeficiency virus infection].
Afani S A; Gallardo O AM
Rev Chilena Infectol; 2011 Oct; 28(5):461-9. PubMed ID: 22051623
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of HIV-1 persistence and evolving strategies for virus eradication.
Dhamija N; Rawat P; Mitra D
Subcell Biochem; 2013; 61():479-505. PubMed ID: 23150264
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genotypic testing in clinical practice.
Holodniy M
AIDS Patient Care STDS; 1998 Jul; 12(7):527-31. PubMed ID: 15462003
[No Abstract] [Full Text] [Related]
15. Current concepts in HIV/AIDS.
Martin D
SADJ; 1999 Dec; 54(12):609-15. PubMed ID: 16892569
[No Abstract] [Full Text] [Related]
16. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M
J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471
[TBL] [Abstract][Full Text] [Related]
17. Is there any hope for AIDS?
Wainberg MA
Clin Invest Med; 2004 Feb; 27(1):51-8. PubMed ID: 15061586
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance mutations in HIV type 1 isolates from naive patients eligible for first line antiretroviral therapy in JJ Hospital, Mumbai, India.
Deshpande A; Karki S; Recordon-Pinson P; Fleury HJ
AIDS Res Hum Retroviruses; 2011 Dec; 27(12):1345-7. PubMed ID: 21453163
[TBL] [Abstract][Full Text] [Related]
19. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
[TBL] [Abstract][Full Text] [Related]
20. 25 years of HIV research! ... and what about a vaccine?
Appay V
Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
